Ticker Details
Enliven Therapeutics, Inc.
IPO Date:	February 24, 2023
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$3.73B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.74 | 3.47%
Avg Daily Range (30 D):	$1.52 | 3.66%
Avg Daily Range (90 D):	$1.37 | 3.52%

Institutional Daily Volume
Avg Daily Volume:	.38M
Avg Daily Volume (30 D):	1.63M
Avg Daily Volume (90 D):	1.18M

Trade Size
Avg Trade Size (Sh.):	71
Avg Trade Size (Sh.) (30 D):	78
Avg Trade Size (Sh.) (90 D):	74

Institutional Trades
Total Institutional Trades:	1,376
Avg Institutional Trade:	$1.9M
Avg Institutional Trade (30 D):	$3.33M
Avg Institutional Trade (90 D):	$2.56M
Avg Institutional Trade Volume:	.07M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$2.35M
Avg Closing Trade (30 D):	$12.07M
Avg Closing Trade (90 D):	$6.01M
Avg Closing Volume:	82.57K

News

Jun 27, 2026 @ 4:03 PM What to Know About OrbiMed's $39 Million Enliven T... Source: Jonathan Ponciano

Jun 24, 2026 @ 7:12 PM Medical Hedge Fund Sells 281,000 Shares of Enliven... Source: Brendan Coffey

Jun 1, 2026 @ 9:25 PM Enliven Therapeutics' Chief Medical Officer Sold 5... Source: Robert Izquierdo

Aug 13, 2025 @ 10:15 PM Enliven Posts Loss Beat and Cash Surge Source: Jesterai

Oct 14, 2024 @ 7:05 PM Enliven Therapeutics, Inc. Is a Great Choice for '... Source: Zacks

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-.38	$-.48	$-1.83
Diluted EPS	$-.38	$-.48	$-1.83
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-23.63M	$-29.67M	$-103.69M
Operating Income / Loss	$-27.82M	$-34.29M	$-119.66M
Cost of Revenue
Net Cash Flow	$33.29M	$-2.84M	$-25.28M
PE Ratio